Suppr超能文献

胸外科医生在肺切除术前对戒烟的看法和做法。

Thoracic Surgeons' Beliefs and Practices on Smoking Cessation Before Lung Resection.

机构信息

University of California Davis School of Medicine, Sacramento, California.

Division of Cardiothoracic Surgery, Washington University in St. Louis, St. Louis, Missouri.

出版信息

Ann Thorac Surg. 2019 May;107(5):1494-1499. doi: 10.1016/j.athoracsur.2018.11.055. Epub 2018 Dec 23.

Abstract

BACKGROUND

Smoking is a risk factor for complications after lung resection. Our primary aim was to ascertain thoracic surgeons' beliefs and practices on smoking cessation before lung resection.

METHODS

An anonymous survey was emailed to 846 thoracic surgeons who participate in The Society of Thoracic Surgeons General Thoracic Surgery Database.

RESULTS

The response rate was 23.6% (n = 200). Surgeons were divided when asked whether it is ethical to require that patients quit smoking (yes, n = 96 [48%]) and whether it is fair to have their outcomes affected by patients who do not quit (yes, n = 87 [43.5%]). Most do not require smoking cessation (n = 120 [60%]). Of those who require it, the most common required period of cessation is 2 weeks or more. Most believe that patient factors are the main barrier to quitting (n = 160 [80%]). Risk of disease progression (39% vs 17.5%, p = 0.02) and alienating patients (17.5% vs 8.8%, p = 0.04) were very important considerations of those who do not require smoking cessation versus those who do. Only 19 (9.5%) always refer to a smoking cessation program and prescribe nicotine replacement therapy and even fewer, 9 (4.5%), always refer to a program and prescribe medical therapy.

CONCLUSIONS

Thoracic surgeons are divided on their beliefs and practices regarding smoking cessation before lung resection. Most believe patient factors are the main barrier to quitting and have concerns about disease progression while awaiting cessation. Very few surgeons refer to a smoking cessation program and prescribe nicotine replacement therapy or medical therapy.

摘要

背景

吸烟是肺切除术后并发症的一个危险因素。我们的主要目的是确定胸外科医生在肺切除术前对戒烟的信念和实践。

方法

我们向参与胸外科医师协会普通胸外科数据库的 846 位胸外科医生发送了一份匿名调查。

结果

回复率为 23.6%(n=200)。当被问及要求患者戒烟是否合乎道德(是,n=96[48%])以及是否公平让那些不戒烟的患者的结果受到影响(是,n=87[43.5%])时,外科医生存在分歧。大多数人不要求戒烟(n=120[60%])。在要求戒烟的人中,最常见的戒烟期是 2 周或更长时间。大多数人认为患者因素是戒烟的主要障碍(n=160[80%])。与要求戒烟的人相比,那些不要求戒烟的人认为疾病进展的风险(39%对 17.5%,p=0.02)和疏远患者(17.5%对 8.8%,p=0.04)是非常重要的考虑因素。只有 19 名(9.5%)医生总是推荐参加戒烟计划并开具尼古丁替代疗法,更少的医生(9 名,4.5%)总是推荐参加戒烟计划并开具药物治疗。

结论

胸外科医生在肺切除术前对戒烟的信念和实践存在分歧。大多数人认为患者因素是戒烟的主要障碍,并且在等待戒烟期间对疾病进展感到担忧。很少有外科医生推荐参加戒烟计划并开具尼古丁替代疗法或药物治疗。

相似文献

1
Thoracic Surgeons' Beliefs and Practices on Smoking Cessation Before Lung Resection.胸外科医生在肺切除术前对戒烟的看法和做法。
Ann Thorac Surg. 2019 May;107(5):1494-1499. doi: 10.1016/j.athoracsur.2018.11.055. Epub 2018 Dec 23.
2
Risk Factor Modification Behaviors of Practicing Vascular Surgeons.血管外科执业医师的危险因素修正行为。
Ann Vasc Surg. 2018 Jan;46:90-96. doi: 10.1016/j.avsg.2017.05.010. Epub 2017 May 29.
10
Cardiopulmonary Testing Before Lung Resection: What Are Thoracic Surgeons Doing?肺切除术前心肺检测:胸外科医生在做什么?
Ann Thorac Surg. 2019 Oct;108(4):1006-1012. doi: 10.1016/j.athoracsur.2019.04.057. Epub 2019 Jun 7.

引用本文的文献

1
The impact of smoking on lung cancer patients.吸烟对肺癌患者的影响。
Eur Respir Rev. 2025 Jun 25;34(176). doi: 10.1183/16000617.0175-2024. Print 2025 May.
4
Patterns and Differences in Lung Cancer Treatment: United States, 2015-2020.2015 - 2020年美国肺癌治疗模式与差异
Chest. 2025 Apr;167(4):1218-1231. doi: 10.1016/j.chest.2024.10.033. Epub 2024 Oct 26.

本文引用的文献

2
Timeliness of Care and Lung Cancer Tumor-Stage Progression: How Long Can We Wait?医疗及时性与肺癌肿瘤分期进展:我们能等待多久?
Ann Thorac Surg. 2017 Dec;104(6):1791-1797. doi: 10.1016/j.athoracsur.2017.06.051. Epub 2017 Oct 21.
6
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验